Archive for the ‘Research News’ Category
Tuesday, August 19th, 2008
EAST SETAUKET, N.Y., August 19, 2008 /PRNewswire-FirstCall/ -- Lixte Biotechnology Holdings, Inc. announced today that the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH) and Lixte filed a joint patent application identifying a biomarker, present in many common cancers, that is a target of drugs ...
Posted in Research News | No Comments »
Tuesday, August 19th, 2008
PITTSBURGH--(BUSINESS WIRE)--Aug 19, 2008 - Cellumen, Inc., a discovery toxicology company, today announced an agreement with Mitsubishi Tanabe Pharma Corporation (MTPC), one of the leading pharmaceutical companies in Japan, to develop panels of biomarkers that identify toxicity early in the drug development process."We're pleased to announce this collaboration with MTPC," ...
Posted in Research News | No Comments »
Tuesday, August 19th, 2008
PENZBERG, Germany--(BUSINESS WIRE)--Aug 19, 2008 - A fast, flexible, and reliable isolation of pure nucleic acids from various sample materials is crucial for sensitive molecular analysis by PCR, RT-PCR, sequencing, arrays etc. In addition, automation of nucleic acid isolation is becoming increasingly important for reproducibility and to reduce experimental error. ...
Posted in Research News | No Comments »
Tuesday, August 19th, 2008
BOTHELL, Wash.--(BUSINESS WIRE)--Aug. 19, 2008 - MDRNA, Inc. (Nasdaq: MRNA) announced today that it has signed an exclusive license agreement to intellectual property from the University of Michigan covering cationic peptides for enhanced delivery of nucleic acids. Terms of the agreement were not disclosed."The University of Michigan peptides have unique ...
Posted in Research News | No Comments »
Tuesday, August 19th, 2008
STANFORD, Calif.--(BUSINESS WIRE)--Aug. 18, 2008 - Human embryonic stem cells trigger an immune response in mice, researchers from the Stanford University School of Medicine report. The finding suggests that the effectiveness of human therapies derived from the cells could be limited unless ways are found to dampen the rejection response.The ...
Posted in Research News | No Comments »
Tuesday, August 19th, 2008
NEW HAVEN, Conn., August 19, 2008 /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC. announced today that it had entered into an agreement with the Dutch-Belgian Cooperative Trial Group for Hematology Oncology (the "HOVON") to conduct a clinical trial of laromustine (Cloretazine(R) (VNP40101M)) with standard remission-induction therapy in patients aged 18-65 with previously ...
Posted in Research News | No Comments »
Tuesday, August 19th, 2008
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug 19, 2008 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the Company has reached agreement with U.S. and E.U. regulatory authorities to proceed with the REALIZE trial, a pivotal Phase 3 clinical trial with the hepatitis C virus (HCV) protease inhibitor telaprevir in combination therapy for ...
Posted in Research News | No Comments »
Tuesday, August 19th, 2008
PALO ALTO, Calif., August 19, 2008 /PRNewswire-FirstCall/ -- Telik, Inc. announced today that it has entered into a license agreement with ReceptorBio, Inc. which would enable ReceptorBio to develop and commercialize Telik's oral small molecule insulin receptor activators. These compounds were identified through the application of TRAP(R), Telik's proprietary drug ...
Posted in Research News | No Comments »
Tuesday, August 19th, 2008
HLA-B*5701 biomarker indicates risk for severe adverse reactions to Abacavir / Experts expect more tests for similar markers in the futureVenlo, The Netherlands – August 19, 2008 – QIAGEN (Nasdaq: QGEN; Frankfurt Prime Standard: QIA) today announced that it has introduced a new molecular diagnostic test to type the HLA-B*5701 ...
Posted in Research News | No Comments »
Tuesday, August 19th, 2008
SEATTLE and OSLO, Norway, August 19, 2008 /PRNewswire/ -- Omeros Corporation, a Seattle-based clinical-stage biopharmaceutical company, and Affitech AS, a Norwegian human antibody therapeutics company, today announced that they have entered into an agreement for the discovery and development of fully human antibodies for Omeros' MASP-2 program. MASP-2, or mannan-binding ...
Posted in Research News | No Comments »
Tuesday, August 19th, 2008
SAN DIEGO, Aug. 19 /PRNewswire-FirstCall/ -- Vical Incorporated (NASDAQ:VICL) today announced a research collaboration with the Karolinska Institute, a leading European medical university, and the Swedish Institute for Infectious Disease Control (SMI), a governmental expert agency, to evaluate Vical's Vaxfectin(R) adjuvant with the Biojector(R) 2000 needle-free injection system (Bioject Medical ...
Posted in Research News | No Comments »
Tuesday, August 19th, 2008
BUDAPEST, Hungary, August 19, 2008 /PRNewswire/ -- ChemAxon, a software solutions provider for cheminformatics today announced the launch of version 5.1 of their cheminformatics toolkits, Marvin & JChem. As well as other improvements, the release sees the introduction of IUPAC name import, support for OLE 2 format useful for integrating ...
Posted in Research News | No Comments »
Tuesday, August 19th, 2008
ATHENS, Georgia, Aug. 19 /PRNewswire/ -- ArunA Biomedical, Inc., a leader in human embryonic stem cell derived products, announced today that it has entered into an exclusive worldwide technology licensing agreement with the University of Georgia Research Foundation that will enable the company to commercialize human mesenchymal cells developed at ...
Posted in Research News | No Comments »
Tuesday, August 19th, 2008
Medical Research News A team of scientists from Oxford ...
Posted in Research News | No Comments »
Tuesday, August 19th, 2008
Medical Research News Many drugs once considered Charles Atlases ...
Posted in Research News | No Comments »
